GDF-15 protects from macrophage accumulation in a mousemodel of advanced atherosclerosis

European Journal of Medical Research

Volumn 18, Issue 1, 2013, Pages

  Preusch, Michael R ^a   Baeuerle, Matthias ^a   Albrecht, Claudia ^a   Blessing, Erwin ^a   Bischof, Marc ^a   Katus, Hugo A ^a   Bea, Florian ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Hospital Freudenstadt   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH DIFFERENTIATION FACTOR 15; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN RECEPTOR; CELL ADHESION MOLECULE; GDF15 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA SINUS; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROSIS; BIOACCUMULATION; BONE MARROW; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MOUSE; NONHUMAN; WHOLE BODY RADIATION; ANIMAL; BONE MARROW TRANSPLANTATION; CELL ADHESION; DISEASE MODEL; GENETICS; HUMAN; LD 50; METABOLISM; PATHOLOGY; RADIATION EXPOSURE;

ANIMALS; ATHEROSCLEROSIS; BONE MARROW TRANSPLANTATION; CELL ADHESION; CELL ADHESION MOLECULES; DISEASE MODELS, ANIMAL; GROWTH DIFFERENTIATION FACTOR 15; HUMANS; LETHAL DOSE 50; MACROPHAGES; MICE; RECEPTORS, LDL; WHOLE-BODY IRRADIATION;

EID: 84879244413     PISSN: 09492321     EISSN: 2047783X     Source Type: Journal    
DOI: 10.1186/2047-783X-18-19     Document Type: Article

References (32)

1. An overview of cytokine interactions in atherosclerosis and implications for peripheral arterial disease. Girn HR, Orsi NM, Homer-Vanniasinkam S, Vasc Med 2007 12 299 309
2. Disruption of TGF-beta signalling in T cells accelerates atherosclerosis. Robertson AK, Rudling M, Zhou X, Gorelik L, Flavell RA, Hansson GK, J Clin Invest 2003 112 1342 1350
3. TGF-beta in the cardiovascular system: molecular mechanisms of a context-specific growth factor. Topper JN, Trends Cardiovasc Med 2000 10 132 137
4. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY, Zhang HP, Donnellan M, Mahler S, Pryor K, Walsh BJ, Nicholson RC, Fairlie WD, Por SB, Robbins JM, Breit SN, Proc Natl Acad Sci U S A 1997 94 11514 11519
5. Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. Welsh JB, Sapinoso LM, Kern SG, Brown DA, Liu T, Bauskin AR, Ward RL, Hawkins NJ, Quinn DI, Russell PJ, Sutherland RL, Breit SN, Moskaluk CA, Frierson HF Jr, Hampton GM, Proc Natl Acad Sci U S A 2003 100 3410 3415
6. Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions. Schlittenhardt D, Schober A, Strelau J, Bonaterra GA, Schmiedt W, Unsicker K, Metz J, Kinscherf R, Cell Tissue Res 2004 318 325 333
7. The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. Kempf T, Eden M, Strelau J, Naguib M, Willenbockel C, Tongers J, Heineke J, Kotlarz D, Xu J, Molkentin JD, Niessen HW, Drexler H, Wollert KC, Circ Res 2006 98 351 360
8. GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation. Xu J, Kimball TR, Lorenz JN, Brown DA, Bauskin AR, Klevitsky R, Hewett TE, Breit SN, Molkentin JD, Circ Res 2006 98 342 350
9. Gene expression pattern in biomechanically stretched cardiomyocytes: evidence for a stretch-specific gene program. Frank D, Kuhn C, Brors B, Hanselmann C, Lüdde M, Katus HA, Frey N, Hypertension 2008 51 309 318
10. Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome. Wollert KC, Kempf T, Peter T, Olofsson S, James S, Johnston N, Lindahl B, Horn-Wichmann R, Brabant G, Simoons ML, Armstrong PW, Califf RM, Drexler H, Wallentin L, Circulation 2007 115 962 971
11. Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome. Wollert KC, Kempf T, Lagerqvist B, Lindahl B, Olofsson S, Allhoff T, Peter T, Siegbahn A, Venge P, Drexler H, Wallentin L, Circulation 2007 116 1540 1548
12. Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction. Kempf T, Björklund E, Olofsson S, Lindahl B, Allhoff T, Peter T, Tongers J, Wollert KC, Wallentin L, Eur Heart J 2007 28 2858 2865
13. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure. Kempf T, von Haehling S, Peter T, Allhoff T, Cicoira M, Doehner W, Ponikowski P, Filippatos GS, Rozentryt P, Drexler H, Anker SD, Wollert KC, J Am Coll Cardiol 2007 50 1054 1060
14. Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Mallat Z, Gojova A, Marchiol-Fournigault C, Esposito B, Kamaté C, Merval R, Fradelizi D, Tedgui A, Circ Res 2001 89 930 934
15. Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression. Lutgens E, Gijbels M, Smook M, Heeringa P, Gotwals P, Koteliansky VE, Daemen MJ, Arterioscler Thromb Vasc Biol 2002 22 975 982
16. GDF15, a cardioprotective TGF-beta superfamily protein. Ago T, Sadoshima J, Circ Res 2006 98 294 297
17. Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis. de Jager SC, Bermúdez B, Bot I, Koenen RR, Bot M, Kavelaars A, de Waard V, Heijnen CJ, Muriana FJ, Weber C, van Berkel TJ, Kuiper J, Lee SJ, Abia R, Biessen EA, J Exp Med 2011 208 217 225
18. Progressive postnatal motoneuron loss in mice lacking GDF-15. Strelau J, Strzelczyk A, Rusu P, Bendner G, Wiese S, Diella F, Altick AL, von Bartheld CS, Klein R, Sendtner M, Unsicker K, J Neurosci 2009 29 13640 13648
19. Demonstration of all connective tissue elements in a single section; pentachrome stains. Movat HZ, AMA Arch Pathol 1955 60 289 295
20. Demonstration of phosphates in calcium deposits: a modification of von Kossa's reaction. Puchtler H, Meloan SN, Histochemistry 1978 56 177 185
21. Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer. Skipworth RJ, Deans DA, Tan BH, Sangster K, Paterson-Brown DA, Hunter M, Breit SN, Ross JA, Fearon KC, Br J Cancer 2010 102 665 672
22. Genetic background selectively influences innominate artery atherosclerosis: immune system deficiency as a probe. Reardon CA, Blachowicz L, Lukens J, Nissenbaum M, Getz GS, Arterioscler Thromb Vasc Biol 2003 23 1449 1454
23. Monocyte/macrophage recruitment and expression of endothelial adhesion proteins in human atherosclerotic lesions. Duplàa C, Couffinhal T, Labat L, Moreau C, Petit-Jean ME, Doutre MS, Lamazière JM, Bonnet J, Atherosclerosis 1996 121 253 266
24. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. Davies MJ, Gordon JL, Gearing AJ, Pigott R, Woolf N, Katz D, Kyriakopoulos A, J Pathol 1993 171 223 229
25. Intercellular adhesion molecule-1 and vascular endothelial growth factor expression kinetics in macrophage-derived foam cells. Yang PY, Rui YC, Life Sci 2003 74 471 480
26. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R, N Engl J Med 1997 336 1276 1282
27. Mechanical properties of model atherosclerotic lesion lipid pools. Loree HM, Tobias BJ, Gibson LJ, Kamm RD, Small DM, Lee RT, Arterioscler Thromb 1994 14 230 234
28. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Sukhova GK, Schönbeck U, Rabkin E, Schoen FJ, Poole AR, Billinghurst RC, Libby P, Circulation 1999 99 2503
29. Assessment of unstable atherosclerosis in mice. Jackson CL, Bennett MR, Biessen EA, Johnson JL, Krams R, Arterioscler Thromb Vasc Biol 2007 27 714 720
30. Atherosclerosis progression in LDL receptor-deficient and apolipoprotein E-deficient mice is independent of genetic alterations in plasminogen activator inhibitor-1. Sjöland H, Eitzman DT, Gordon D, Westrick R, Nabel EG, Ginsburg D, Arterioscler Thromb Vasc Biol 2000 20 846 852
31. Mouse models of atherosclerosis. Breslow JL, Science 1996 272 685 688
32. Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1. Johnen H, Lin S, Kuffner T, Brown DA, Tsai VW, Bauskin AR, Wu L, Pankhurst G, Jiang L, Junankar S, Hunter M, Fairlie WD, Lee NJ, Enriquez RF, Baldock PA, Corey E, Apple FS, Murakami MM, Lin EJ, Wang C, During MJ, Sainsbury A, Herzog H, Breit SN, Nat Med 2007 13 1333 1340